| 000 | 01867 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516210132.0 | ||
| 264 | 0 | _c20140808 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/jm500033r _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVidenović, Milica | |
| 245 | 0 | 0 |
_aSecond generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cMay 2014 |
||
| 300 |
_a4134-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminoquinolines _xchemical synthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimalarials _xchemical synthesis |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 |
_aChloroquine _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetalloproteases _xdrug effects |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aOpsenica, Dejan M | |
| 700 | 1 | _aBurnett, James C | |
| 700 | 1 | _aGomba, Laura | |
| 700 | 1 | _aNuss, Jonathan E | |
| 700 | 1 | _aSelaković, Zivota | |
| 700 | 1 | _aKonstantinović, Jelena | |
| 700 | 1 | _aKrstić, Maja | |
| 700 | 1 | _aSegan, Sandra | |
| 700 | 1 | _aZlatović, Mario | |
| 700 | 1 | _aSciotti, Richard J | |
| 700 | 1 | _aBavari, Sina | |
| 700 | 1 | _aSolaja, Bogdan A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 57 _gno. 10 _gp. 4134-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm500033r _zAvailable from publisher's website |
| 999 |
_c23746412 _d23746412 |
||